Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery.
about
Kinases as druggable targets in trypanosomatid protozoan parasitesStructure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoniNew compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.Essential multimeric enzymes in kinetoplastid parasites: A host of potentially druggable protein-protein interactions.EVALUATION OF AROMATIC 6-SUBSTITUTED THIENOPYRIMIDINES AS SCAFFOLDS AGAINST PARASITES THAT CAUSE TRYPANOSOMIASIS, LEISHMANIASIS, AND MALARIA.Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery.Identification of "Preferred" Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases.Genome-wide and protein kinase-focused RNAi screens reveal conserved and novel damage response pathways in Trypanosoma brucei.Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.RNAi screening identifies Trypanosoma brucei stress response protein kinases required for survival in the mouse.Structural optimization and evaluation of novel 2-pyrrolidone-fused (2-oxoindolin-3-ylidene)methylpyrrole derivatives as potential VEGFR-2/PDGFRβ inhibitors.Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.Design, Synthesis, and Characterization of Novel Small Molecules as Broad Range Antischistosomal AgentsSeries of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite Proliferation
P2860
Q26786761-FC5537FB-E37E-4854-B414-5F34C25A9D37Q28552326-0839CFE8-E1AD-46BC-84A1-A03142F47A5FQ30417002-E5E1EE15-717C-4F0F-B0EF-EAC19DF988C3Q33898663-0BE91024-DB99-466E-A43E-52953F530EEEQ35072529-672D897F-5967-4967-9FF3-068AA6465ECDQ35891268-9804F6EF-714D-4E97-A204-514727A40291Q36686364-68A279B4-38EF-4BC4-8243-5A5EDEB276ABQ38939544-67E0C605-D245-4F6D-B3F8-8851D0A7A2FAQ38972808-379EA1F6-2700-47BC-BDD3-85EEC1FD2C3DQ39492733-695E6449-CD62-4F73-A105-881A28942C70Q40051127-62B8BDBD-926C-4CE1-B1EA-463488A389FEQ40124264-A99A53B4-3470-4181-A889-793C04AF094AQ42877991-AD39E193-D9A0-4B34-AB55-61C91AC08CDCQ45305049-55008743-D2DC-43FD-84A6-5CBA003DAA6AQ57822205-0B9688FB-0C9C-4D0C-A338-6871B4C162D8Q57822499-3427A39A-0FDD-49D6-9A83-420D94BB8DD2
P2860
Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery.
@en
type
label
Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery.
@en
prefLabel
Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery.
@en
P2093
P2860
P50
P356
P1433
P1476
Repurposing human Aurora kinase inhibitors as leads for anti-protozoan drug discovery.
@en
P2093
Gautam Patel
Norma E Roncal
Patricia J Lee
Susan E Leed
P2860
P304
P356
10.1039/C4MD00045E
P577
2014-05-01T00:00:00Z